mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |